Rheumatology leaders say FDA biosimilar interchangeability guidance a balanced approach

Experts from the American College of Rheumatology (ACR), Food and Drug Administration (FDA), and other leading national healthcare groups spoke about the emerging biosimilars market, including key policy and regulatory questions …